T-Cell Depletion: Its evolution as a method for preventing GVHD and its potential as a platform for targeted immunotherapies


2014 BMT Tandem Meetings
E. Donnall Thomas Lecture
Richard J. O'Reilly, MD, Memorial Sloan Kettering Cancer Center